NRC Health

NRC ·Healthcare, Diagnostics & Research, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $4.1M $4.2M $6.7M $25.0M $54.4M $34.7M $13.5M $13.0M
Accounts Receivable $11.1M $11.1M $12.4M $14.5M $13.7M $13.9M $11.6M $11.9M
Inventory — — — — — — — —
Total Current Assets $20.2M $19.6M $24.4M $43.7M $73.7M $54.1M $29.2M $28.4M
Property, Plant & Equipment — — $28.2M $17.2M $12.4M $11.7M $13.5M $14.2M
Goodwill $66.2M $66.2M $61.6M $61.6M $61.6M $57.3M $57.9M $57.8M
Intangible Assets (Excl. Goodwill) $2.2M $2.6M $1.5M $1.6M $1.8M $1.4M $1.7M $2.1M
Total Assets $134.9M $132.5M $122.4M $130.5M $157.5M $133.4M $110.7M $108.0M
Liabilities
Accounts Payable $1.2M $1.2M $1.3M $1.2M $1.9M $1.1M $1.3M $613.0K
Total Current Liabilities $36.6M $35.9M $36.2M $33.4M $40.4M $31.7M $38.2M $47.1M
Long-Term Debt $75.0M $57.9M $29.5M $22.3M $26.6M $26.5M $29.8M $34.2M
Total Liabilities $120.9M $101.3M $73.5M $58.4M $72.2M $69.1M $77.8M $88.9M
Stockholders' Equity
Retained Earnings $-17.3M $-17.1M $-30.5M $-25.2M $-36.1M $-61.4M $-93.4M $-106.3M
Total Stockholders' Equity $14.0M $31.3M $49.0M $72.0M $85.3M $64.3M $32.9M $19.1M
← Newer Page 1 of 2 Older →